Literature DB >> 29998328

Testosterone Prescribing in the United States, 2002-2016.

Jacques Baillargeon1, Yong-Fang Kuo1, Jordan R Westra1, Randall J Urban2, James S Goodwin2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29998328      PMCID： PMC6396809          DOI： 10.1001/jama.2018.7999

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  28 in total

1.  Trends and Patterns of Testosterone Therapy among U.S. Male Medicare Beneficiaries, 1999 to 2014.

Authors:  Cindy Ke Zhou; Shailesh Advani; Matthew Chaloux; James Todd Gibson; Mandi Yu; Marie Bradley; Robert N Hoover; Michael B Cook
Journal:  J Urol       Date:  2020-01-13       Impact factor: 7.450

2.  Testosterone Therapy in Relation to Prostate Cancer in a U.S. Commercial Insurance Claims Database.

Authors:  Michael B Cook; Daniel C Beachler; Lauren E Parlett; Philip T Cochetti; William D Finkle; Stephan Lanes; Robert N Hoover
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10-22       Impact factor: 4.254

3.  Testosterone Prescribing Among Women in the USA, 2002-2017.

Authors:  Jacques Baillargeon; Randall J Urban; Mukaila A Raji; Jordan R Westra; Stephen B Williams; David S Lopez; Yong-Fang Kuo
Journal:  J Gen Intern Med       Date:  2019-10-21       Impact factor: 5.128

Review 4.  Paediatric and adult-onset male hypogonadism.

Authors:  Andrea Salonia; Giulia Rastrelli; Geoffrey Hackett; Stephanie B Seminara; Ilpo T Huhtaniemi; Rodolfo A Rey; Wayne J G Hellstrom; Mark R Palmert; Giovanni Corona; Gert R Dohle; Mohit Khera; Yee-Ming Chan; Mario Maggi
Journal:  Nat Rev Dis Primers       Date:  2019-05-30       Impact factor: 52.329

5.  Testosterone Imposters: An Analysis of Popular Online Testosterone Boosting Supplements.

Authors:  Adithya Balasubramanian; Nannan Thirumavalavan; Ashwin Srivatsav; Justin Yu; Larry I Lipshultz; Alexander W Pastuszak
Journal:  J Sex Med       Date:  2019-02       Impact factor: 3.802

6.  Iron status and risk factors for iron depletion in a racially/ethnically diverse blood donor population.

Authors:  Bryan R Spencer; Yuelong Guo; Ritchard G Cable; Joseph E Kiss; Michael P Busch; Grier P Page; Stacy M Endres-Dighe; Steven Kleinman; Simone A Glynn; Alan E Mast
Journal:  Transfusion       Date:  2019-07-18       Impact factor: 3.157

7.  Canadian trends in testosterone therapy.

Authors:  Jesse Ory; Joshua Theodore White; Jonathan Moore; John Grantmyre
Journal:  Can Urol Assoc J       Date:  2021-06       Impact factor: 1.862

8.  Testosterone therapy: Prescribing and monitoring patterns of practice in British Columbia.

Authors:  Jennifer A Locke; Ryan Flannigan; Oliver P Günther; Sean Skeldon; S Larry Goldenberg
Journal:  Can Urol Assoc J       Date:  2021-02       Impact factor: 1.862

9.  Association of the extent of therapy with prostate cancer in those receiving testosterone therapy in a US commercial insurance claims database.

Authors:  David S Lopez; Danmeng Huang; Konstantinos K Tsilidis; Mohit Khera; Stephen B Williams; Randall J Urban; Orestis A Panagiotou; Yong-Fang Kuo; Jacques Baillargeon; Albert Farias; Trudy Krause
Journal:  Clin Endocrinol (Oxf)       Date:  2019-10-07       Impact factor: 3.478

10.  Association of Testosterone Therapy With Risk of Venous Thromboembolism Among Men With and Without Hypogonadism.

Authors:  Rob F Walker; Neil A Zakai; Richard F MacLehose; Logan T Cowan; Terrence J Adam; Alvaro Alonso; Pamela L Lutsey
Journal:  JAMA Intern Med       Date:  2020-02-01       Impact factor: 21.873
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.